InvestorsHub Logo
Followers 135
Posts 13914
Boards Moderated 0
Alias Born 09/05/2013

Re: None

Wednesday, 05/18/2022 10:44:10 AM

Wednesday, May 18, 2022 10:44:10 AM

Post# of 9333
"Monoamine Receptor and Transporter Interaction Profiles of 4-Alkyl-Substituted 2,5-Dimethoxyamphetamines":
13 May 2022
Dino Luethi,Deborah Rudin,Marius C. Hoener, Matthias E. Liechti

Abstract
Background
Various ring-substituted phenethylamines and amphetamines are used recreationally due to their mind-altering effects. Furthermore, such psychedelic substances have recently gained increased interest as prospective therapeutics. Here, we studied the pharmacological properties of 4-alkylated 2,5-dimethoxyamphetamines in vitro. Specifically, we assessed the effect of the 4-alkyl chain length on interactions with monoaminergic targets. We aimed to test the hypothesis that the derivatives with the highest clinical potency display the most potent serotonin (5-HT) type 2A receptor interactions, which is the key driver of psychedelic effects.

Methods
We determined binding affinities of 2,5-dimethoxyamphetamine (2,5-DMA), 4-methyl-2,5-dimethoxyamphetamine (DOM), 4-ethyl-2,5-dimethoxyamphetamine (DOET), 4-butyl-2,5-dimethoxyamphetamine (DOBU), and 4-amyl-2,5-dimethoxyamphetamine (DOAM) at serotonergic, adrenergic, and dopaminergic receptors and transporters, as well as at the trace amine-associated receptor 1 (TAAR1). For this, we assessed radioligand displacement using cell membrane preparations expressing the respective targets. Furthermore, we determined the functional activity of the derivatives at the 5-HT2A and 5-HT2B receptors by measuring calcium mobilization and at the TAAR1 by measuring cAMP accumulation. In addition, we assessed whether any of the derivatives inhibit transporter-mediated uptake of radiolabeled monoamines.

Results
Unlike 2,5-DMA, its 4-alkylated derivatives displayed potent (i.e., nanomolar) affinity at 5-HT2A and 5-HT2C receptors. Increasing length of the 4-alkyl chain increased the selectivity for 5-HT2A vs. 5-HT1A and 5-HT2C receptors. Whereas DOM and DOET activated the 5-HT2B receptor as partial agonists in the nanomolar range (EC50: 68–128 nM, Emax: 73–85%), DOBU and DOAM did not activate the receptor at investigated concentrations (EC50 > 10,000 nM). In contrast to the potent interactions with 5-HT2 receptors, the 4-alkyl-substituted 2,5-dimethoxyamphetamines did not or only weakly (i.e., in the micromolar range) interact with other monoaminergic targets.

Conclusion
Among the tested substances, user reports suggest DOM and DOET to be the only derivatives with a distinct psychedelic effect profile. Our data therefore indicate that 5-HT2A and 5-HT2C receptor affinity alone is not a sufficient predictor for the clinical and psychedelic potency of 4-substituted 2,5-dimethoxyamphetamines. To assess the clinical potential of the tested substances, future studies should focus in more detail on pharmacokinetics and qualitative differences in 5-HT2 receptor activation.


https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.2022.36.S1.R2691
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News